Answers are grounded in this paper and cite their sources.
Analysis of 21 million transactions demonstrates that digital prescriptions improve influenza outbreak response, suggesting enhanced surveillance techniques.
Traditional influenza surveillance suffers from 1-2 week reporting delays that compromise outbreak response. We analyzed 21.08 million digital prescription transactions from China's largest on-demand medication delivery platform across 31 provinces (2022-2024) and demonstrated that prescription data provide causally validated epidemic proxies. Digital prescriptions exhibited 2-week predictive lead time (convergent cross-mapping skills ΔρCCM = 0.339; p < 0.001; 28/31 provinces), substantially exceeding environmental predictors (ΔρCCM = 0.032-0.196) while matching online search indices (ΔρCCM = 0.349). Critically, prescriptions demonstrated bidirectional causal coupling with laboratory-confirmed influenza positivity (forward: 28/31; reverse: 22/31 provinces). This dynamical signature was absent in online search (reverse: 2/31) and environmental variables (reverse: 0-5/31), distinguishing validated disease signals from confounded correlates. Prescriptions also exhibited greater environmental sensitivity compared with laboratory surveillance (air pollutants: 14-26/31 versus 3-7/31 provinces). Leveraging this validated proxy, a spatiotemporal deep learning framework integrating GNN, Mamba, and LSTM achieved 96-day forecasting of daily prescription rates (mean absolute error (MAE) = 1.166; MAE < 3.0 in 29/31 provinces). Digital prescriptions thus enable both immediate epidemic detection (24 h data availability) and actionable long-range forecasting, providing an additional validated data stream for multi-source epidemic surveillance.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: